Opening the Conversation With Patients Around CML Concerns

News
Video

Care teams should maintain frequent communication with patients with chronic myeloid leukemia to ensure best outcomes, even between appointments.

Clinical teams should encourage patients with chronic myeloid leukemia (CML) to discuss complications from their treatment, even if their next appointment if months away, an expert said.

Jorge E. Cortes, MD, director of the Georgia Cancer Center at Augusta University, spoke with Oncology Nursing News at the 2024 American Society of Clinical Oncology Annual Meeting. He emphasized that patients should be active participants in their CML care by having goals of care and open lines of communication with their health care team.

“Always express everything that you're feeling. Certainly not everything that happens is from the disease or from the treatment, but at least bring it up,” he said.

Transcript:

One important thing is that the goals of therapy [and] the assessment of the quality of life of the impact, is [the patient’s goals]. It's not the physician. Our role is to guide them. What the patients’ goals are is for them.

The significance of this, [is that] there are side effects that I can quantitate because there are tests. [For example,] how much the elevation of the live transaminase — that's a test. But a lot of these are depend on the patient.

So always make sure that you communicate properly … Always express everything that you're feeling. Certainly not everything that happens is from the disease or from the treatment, but at least bring it up. Make sure that you had a constant flow of communication even between visits to make sure that if something happens, your doctor knows and is able to help you. Do not wait until the next visit in three or six months.

Recent Videos
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Jessica MacIntyre, DNP, MBA, APRN, NP-C, AOCNP, in an interview with Oncology Nursing News
Related Content
© 2024 MJH Life Sciences

All rights reserved.